Alwine B Kruisselbrink - JoVE Visualize

Showing results (1-10 of 27) with videos related to

Pageof 3

Sort By:

Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 11, 2014

Collateral damage of nonhematopoietic tissue by hematopoiesis-specific T cells results in graft-versus-host disease during an ongoing profound graft-versus-leukemia reactionBoris van der Zouwen, Alwine B Kruisselbrink, J H Frederik Falkenburg, et al.

Journal of Immunology (Baltimore, Md. : 1950)|August 5, 2006

Mesenchymal stem cells inhibit generation and function of both CD34+-derived and monocyte-derived dendritic cellsAlma J Nauta, Alwine B Kruisselbrink, Ellie Lurvink, et al.

Blood|May 13, 2006

Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative settingAlma J Nauta, Geert Westerhuis, Alwine B Kruisselbrink, et al.

Journal of Bone Oncology|February 16, 2019

Exploration of the chondrosarcoma metabolome; the mTOR pathway as an important pro-survival pathwayRuben D Addie, Yvonne de Jong, Gaia Alberti, et al.

Experimental Hematology|October 13, 2005

Enhanced engraftment of umbilical cord blood-derived stem cells in NOD/SCID mice by cotransplantation of a second unrelated cord blood unitAlma J Nauta, Alwine B Kruisselbrink, Ellie Lurvink, et al.

Frontiers in Immunology|March 15, 2018

Tissue Damage Caused by Myeloablative, but Not Non-Myeloablative, Conditioning before Allogeneic Stem Cell Transplantation Results in Dermal Macrophage Recruitment without Active T-Cell InteractionPeter van Balen, Boris van der Zouwen, Alwine B Kruisselbrink, et al.

Cancers|August 7, 2021

SUMOylation Is Associated with Aggressive Behavior in Chondrosarcoma of BoneJessie S Kroonen, Alwine B Kruisselbrink, Inge H Briaire-de Bruijn, et al.

Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 17, 2012

Alloreactive effector T cells require the local formation of a proinflammatory environment to allow crosstalk and high avidity interaction with nonhematopoietic tissues to induce GVHD reactivityBoris van der Zouwen, Alwine B Kruisselbrink, Ekaterina S Jordanova, et al.

Experimental Hematology|October 11, 2003

Nonexpanded primary lung and bone marrow-derived mesenchymal cells promote the engraftment of umbilical cord blood-derived CD34(+) cells in NOD/SCID micePieternella S in 't Anker, Willy A Noort, Alwine B Kruisselbrink, et al.

Cancers|December 8, 2019

Inhibition of PARP Sensitizes Chondrosarcoma Cell Lines to Chemo- and Radiotherapy Irrespective of the IDH1 or IDH2 Mutation StatusSanne Venneker, Alwine B Kruisselbrink, Inge H Briaire-de Bruijn, et al.

Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:

Pageof 3

Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 11, 2014

Collateral damage of nonhematopoietic tissue by hematopoiesis-specific T cells results in graft-versus-host disease during an ongoing profound graft-versus-leukemia reactionBoris van der Zouwen, Alwine B Kruisselbrink, J H Frederik Falkenburg, et al.

Journal of Immunology (Baltimore, Md. : 1950)|August 5, 2006

Mesenchymal stem cells inhibit generation and function of both CD34+-derived and monocyte-derived dendritic cellsAlma J Nauta, Alwine B Kruisselbrink, Ellie Lurvink, et al.

Blood|May 13, 2006

Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative settingAlma J Nauta, Geert Westerhuis, Alwine B Kruisselbrink, et al.

Journal of Bone Oncology|February 16, 2019

Exploration of the chondrosarcoma metabolome; the mTOR pathway as an important pro-survival pathwayRuben D Addie, Yvonne de Jong, Gaia Alberti, et al.

Experimental Hematology|October 13, 2005

Enhanced engraftment of umbilical cord blood-derived stem cells in NOD/SCID mice by cotransplantation of a second unrelated cord blood unitAlma J Nauta, Alwine B Kruisselbrink, Ellie Lurvink, et al.

Frontiers in Immunology|March 15, 2018

Tissue Damage Caused by Myeloablative, but Not Non-Myeloablative, Conditioning before Allogeneic Stem Cell Transplantation Results in Dermal Macrophage Recruitment without Active T-Cell InteractionPeter van Balen, Boris van der Zouwen, Alwine B Kruisselbrink, et al.

Cancers|August 7, 2021

SUMOylation Is Associated with Aggressive Behavior in Chondrosarcoma of BoneJessie S Kroonen, Alwine B Kruisselbrink, Inge H Briaire-de Bruijn, et al.

Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 17, 2012

Alloreactive effector T cells require the local formation of a proinflammatory environment to allow crosstalk and high avidity interaction with nonhematopoietic tissues to induce GVHD reactivityBoris van der Zouwen, Alwine B Kruisselbrink, Ekaterina S Jordanova, et al.

Experimental Hematology|October 11, 2003

Nonexpanded primary lung and bone marrow-derived mesenchymal cells promote the engraftment of umbilical cord blood-derived CD34(+) cells in NOD/SCID micePieternella S in 't Anker, Willy A Noort, Alwine B Kruisselbrink, et al.

Cancers|December 8, 2019

Inhibition of PARP Sensitizes Chondrosarcoma Cell Lines to Chemo- and Radiotherapy Irrespective of the IDH1 or IDH2 Mutation StatusSanne Venneker, Alwine B Kruisselbrink, Inge H Briaire-de Bruijn, et al.

Pageof 3